Literature DB >> 328920

Mutational approaches to the study of carcinogenesis.

E H Chu, J E Trosko, C C Chang.   

Abstract

A number of circumstantial lines of evidence are consistent with the somatic mutation theory of carcinogenesis, but there has been a paucity of experimental data that either support or contradict the genetic theory. In this paper, we summarize the predictions, the recent experimental approaches, and the problems involved in testing the theory. Results are presented that define the conditions and demonstrate the existence of two-stage processes of mutagenesis and carcinogenesis in vitro. We conclude that mutagenesis is responsible for the initiation of carcinogenesis and an epigenetic mechanism is responsible for its promotion. Carcinogenic agents can induce a stable transformation of a cell by either mutation or epigenetic alteration in gene expression. This conclusion has led us to propose a new integrative theory of carcinogenesis, encompassing the tenets of four main theories: (1) the mutation and epigenetic basis for carcinogenesis, (2) the two-stage theory of carcinogenesis, (3) a general theory of carcinogenesis, and (4) the somatic deletion mutation theory of carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 328920     DOI: 10.1080/15287397709529533

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  3 in total

1.  Mutagenicity of melanin from human red hair.

Authors:  Z P Harsanyi; P W Post; J P Brinkmann; M R Chedekel; R M Deibel
Journal:  Experientia       Date:  1980-03-15

2.  Mutagen-induced resistance to mycophenolic acid in hamster cells can be associated with increased inosine 5'-phosphate dehydrogenase activity.

Authors:  E Huberman; C K McKeown; J Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

3.  Induction of ouabain-resistant mutations in C3H 10T1/2 mouse cells by ultraviolet light.

Authors:  G L Chan; J B Little
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.